1-3 of 3
Giamal Gmati, MD
Close
Sort by
Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC
Journal: Blood
Blood (2017) 130 (Supplement 1): 2799.
https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799
Published: 2017
Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5549.
https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549
Published: 2017
Journal Articles

The Hybrid Regimen of ABVD/BEACOPP May Overcome the High-Risk Features of the Advanced Stage Hodgkin Lymphoma

Ahmed Alaskar, MD, Ahmad Al Ameer, Gasmelseed Ahmed, MD, Ayman Alhejazi, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Mushtaq Rather, MD, Mohsen Al Zahrani, MD
Journal: Blood
Blood (2014) 124 (21): 5477.
https://doi.org/10.1182/blood.V124.21.5477.5477
Published: 2014